Physician profile
Koijan S Kainth
NPI 1346488038
$1,261,007.70
in general payments reported to CMS, 2019-2025
29 companies · $241K in 2025
The $241K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,266 · 2020: $88K · 2021: $241K · 2022: $241K · 2023: $231K · 2024: $217K · 2025: $241K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $686K · Food and Beverage: $2,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $686,000.00 |
| Food and Beverage | $2,533.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $1,254,022.01 | 2020-2025 | |
| Providence Medical Technology, INC. | $2,628.03 | 2019-2025 | |
| Si-Bone, INC. | $1,129.73 | 2019-2022 | |
| Vertiflex, INC. | $620.66 | 2019 | |
| Spinal Simplicity, LLC | $358.21 | 2021-2023 | Ha Minuteman G3-R |
| Zimmer Biomet Holdings, INC. | $325.56 | 2019 | |
| Alphatec Spine, INC | $310.76 | 2022-2023 | Solus Alif |
| Spinal Elements, INC. | $263.47 | 2021-2025 | |
| Depuy Synthes Sales INC. | $153.35 | 2021-2024 | Monovisc, Orthovisc |
| Vgi Medical, LLC | $149.50 | 2022 | |
| Intrinsic Therapeutics | $120.48 | 2023 | Barricaid Acd (Annular Closure Device) |
| Cerapedics INC. | $112.83 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Bioventus LLC | $111.43 | 2022-2024 | Bonescalpel & Sonicone (O.R.) |
| Painteq LLC | $94.63 | 2023 | Painteq |
| Boston Scientific Corporation | $93.90 | 2020-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $82.10 | 2021-2024 | Intellis Adaptivestim |
| Nuvasive, INC. | $72.05 | 2019 | |
| Vertos Medical, INC. | $48.82 | 2022 | |
| Globus Medical, INC. | $41.11 | 2022 | |
| Davol INC. | $35.97 | 2022 | |
| Smith+Nephew, INC. | $34.60 | 2025 | Pico 7 |
| Medtronic USA, INC. | $31.93 | 2019 | |
| Stryker Corporation | $30.76 | 2019 | |
| Life Spine, INC. | $27.94 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $26.67 | 2025 | |
| Relievant Medsystems, INC. | $25.55 | 2021 | |
| Misonix INC | $21.10 | 2019 | |
| Heron Therapeutics, INC. | $17.94 | 2024 | Zynrelef |
| Arteriocyte Medical Systems, INC. | $16.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Koijan Kainth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.